{
    "id": 1898,
    "fullName": "KRAS Q61R",
    "impact": "missense",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "KRAS Q61R is a hotspot mutation that lies within a GTP-binding region of the Kras protein (UniProt.org). Q61R has not been characterized, but can be predicted to confer a loss of function on the Kras protein based on the effects of NRAS Q61R, which results in a loss of Nras GTPase function as indicated by increased GTP-bound Nras and subsequent activation of Mapk signaling in culture (PMID: 16818621).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 12302,
                    "pubMedId": 16818621,
                    "title": "Coexpression of NRASQ61R and BRAFV600E in human melanoma cells activates senescence and increases susceptibility to cell-mediated cytotoxicity.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/16818621"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 3845,
        "geneSymbol": "KRAS",
        "terms": [
            "KRAS",
            "'C-K-RAS",
            "C-K-RAS",
            "c-Ki-ras",
            "c-Ki-ras2",
            "CFC2",
            "K-Ras",
            "K-Ras 2",
            "K-RAS2A",
            "K-RAS2B",
            "K-RAS4A",
            "K-RAS4B",
            "KI-RAS",
            "KRAS1",
            "KRAS2",
            "NS",
            "NS3",
            "OES",
            "RALD",
            "RASK2"
        ]
    },
    "variant": "Q61R",
    "createDate": "09/25/2014",
    "updateDate": "10/22/2019",
    "referenceTranscriptCoordinates": {
        "id": 157384,
        "transcript": "NM_033360",
        "gDna": "chr12:g.25227342T>C",
        "cDna": "c.182A>G",
        "protein": "p.Q61R",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15046,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the combination therapy of Selumetinib (AZD6244) and SHP099 resulted in a synergistic effect, demonstrating reduced cell proliferation and decreased colony formation in pancreatic ductal adenocarcinoma cells harboring KRAS Q61R (PMID: 30045908).",
            "molecularProfile": {
                "id": 1865,
                "profileName": "KRAS Q61R"
            },
            "therapy": {
                "id": 7400,
                "therapyName": "Selumetinib + SHP099",
                "synonyms": null
            },
            "indication": {
                "id": 3498,
                "name": "pancreatic ductal adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 12547,
                    "pubMedId": 30045908,
                    "title": "SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30045908"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 18669,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Afinitor (everolimus), Linsitinib (OSI-906), and Mekinist (trametinib) triple combination treatment resulted in tumor regression in urethane-induced lung cancer harboring KRAS Q61R in mouse models (PMID: 31534020).",
            "molecularProfile": {
                "id": 1865,
                "profileName": "KRAS Q61R"
            },
            "therapy": {
                "id": 8786,
                "therapyName": "Everolimus + Linsitinib + Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 16366,
                    "pubMedId": 31534020,
                    "title": "Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31534020"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15058,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, pancreatic ductal adenocarcinoma cells harboring KRAS Q61R demonstrated reduced sensitivity to Selumetinib (AZD6244) in culture when compared to the combined therapy of Selumetinib (AZD6244) and SHP099 (PMID: 30045908).",
            "molecularProfile": {
                "id": 1865,
                "profileName": "KRAS Q61R"
            },
            "therapy": {
                "id": 913,
                "therapyName": "Selumetinib",
                "synonyms": null
            },
            "indication": {
                "id": 3498,
                "name": "pancreatic ductal adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 12547,
                    "pubMedId": 30045908,
                    "title": "SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30045908"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1865,
            "profileName": "KRAS Q61R",
            "profileTreatmentApproaches": [
                {
                    "id": 15938,
                    "name": "AZD4785",
                    "profileName": "KRAS Q61R"
                },
                {
                    "id": 15932,
                    "name": "MEK2 Inhibitor",
                    "profileName": "KRAS Q61R"
                },
                {
                    "id": 15933,
                    "name": "PI3K Inhibitor (Pan)",
                    "profileName": "KRAS Q61R"
                },
                {
                    "id": 15935,
                    "name": "PIK3CA inhibitor",
                    "profileName": "KRAS Q61R"
                },
                {
                    "id": 15937,
                    "name": "MEK inhibitor (Pan)",
                    "profileName": "KRAS Q61R"
                },
                {
                    "id": 15934,
                    "name": "RAS Inhibitor (Pan)",
                    "profileName": "KRAS Q61R"
                },
                {
                    "id": 15936,
                    "name": "MEK1 Inhibitor",
                    "profileName": "KRAS Q61R"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 157385,
            "transcript": "XM_017019293",
            "gDna": "chr12:g.25227342T>C",
            "cDna": "c.182A>G",
            "protein": "p.Q61R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 157384,
            "transcript": "NM_033360",
            "gDna": "chr12:g.25227342T>C",
            "cDna": "c.182A>G",
            "protein": "p.Q61R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 157387,
            "transcript": "XM_006719069",
            "gDna": "chr12:g.25227342T>C",
            "cDna": "c.182A>G",
            "protein": "p.Q61R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 157386,
            "transcript": "XM_011520653",
            "gDna": "chr12:g.25227342T>C",
            "cDna": "c.182A>G",
            "protein": "p.Q61R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 157383,
            "transcript": "NM_004985",
            "gDna": "chr12:g.25227342T>C",
            "cDna": "c.182A>G",
            "protein": "p.Q61R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}